RNA

Atrium Therapeutics, Inc.NASDAQHealthcare

$13.44-0.22%ClosedMarket Cap: $208.5M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2025-11-11	Chardan Capital	—	Neutral	—
2025-10-29	TD Cowen	—	Hold	—
2025-10-28	RBC Capital	—	Sector Perform	—
2025-10-27	Raymond James	—	Market Perform	—
2025-10-27	HC Wainwright & Co.	—	Neutral	—
2025-10-27	Leerink Partners	—	Market Perform	—
2025-10-27	Needham	—	Hold	—
2025-10-27	Citigroup	—	Neutral	—
2025-10-27	Bernstein	—	Market Perform	—
2025-09-22	Evercore ISI Group	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-5.04	$21.7M	4
Fri Dec 31	$-4.01	$287.5M	3
Sun Dec 31	$-1.82	$913.0M	6
Mon Dec 31	$1.83	$1.61B	4